Assidi, M.; Yahya, F.M.; Al-Zahrani, M.H.; Elkhatib, R.; Zari, A.; Elaimi, A.; Al-Maghrabi, J.; Dallol, A.; Buhmeida, A.; Abu-Elmagd, M.
Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises. Int. J. Mol. Sci. 2021, 22, 12872.
https://doi.org/10.3390/ijms222312872
AMA Style
Assidi M, Yahya FM, Al-Zahrani MH, Elkhatib R, Zari A, Elaimi A, Al-Maghrabi J, Dallol A, Buhmeida A, Abu-Elmagd M.
Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises. International Journal of Molecular Sciences. 2021; 22(23):12872.
https://doi.org/10.3390/ijms222312872
Chicago/Turabian Style
Assidi, Mourad, Fatimah M. Yahya, Maryam H. Al-Zahrani, Razan Elkhatib, Ali Zari, Aisha Elaimi, Jaudah Al-Maghrabi, Ashraf Dallol, Abdelbaset Buhmeida, and Muhammad Abu-Elmagd.
2021. "Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises" International Journal of Molecular Sciences 22, no. 23: 12872.
https://doi.org/10.3390/ijms222312872
APA Style
Assidi, M., Yahya, F. M., Al-Zahrani, M. H., Elkhatib, R., Zari, A., Elaimi, A., Al-Maghrabi, J., Dallol, A., Buhmeida, A., & Abu-Elmagd, M.
(2021). Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises. International Journal of Molecular Sciences, 22(23), 12872.
https://doi.org/10.3390/ijms222312872